DSpace Kyoto University
Japanese | English 

Kyoto University Research Information Repository >
707 高等研究院 >
Institute for Integrated Cell-Material Sciences (iCeMS) >
Journal Articles >

Access count of this item: 1052

Please use this identifier to cite or link to this item: http://hdl.handle.net/2433/160128

Full text link:

File Description SizeFormat
978-94-007-4531-5_7.pdf616.8 kBAdobe PDFView/Open
Title: Cre/loxP, Flp/FRT Systems and Pluripotent Stem Cell Lines
Authors: Candice G. T. Tahimic
Sakurai, Kenji
Aiba, Kazuhiro researcher_resolver
Nakatsuji, Norio kyouindb researcher_resolver
Author's alias: 饗庭, 一博
Keywords: Cre/loxP system
Flp/FRT system
Pluripotent stem cells
Site-specific recombination
Site-specific transgene integration
Issue Date: 2013
Publisher: Springer Netherlands
Journal title: Topics in Current Genetics
Volume: 23
Start page: 189
End page: 209
Abstract: Cre and FLP recombinases are the most widely used site-specific recombinases in genome engineering. Both are members of the tyrosine class of recombinases and catalyze the reversible, site-specific recombination between two identical sequences of 34 bp length in the absence of accessory factors. The substrate sequences for Cre and Flp recombinases are called loxP and FRT sites respectively. Cre recombinase was discovered in the E. coli bacteriophage P1 where it plays a crucial role in the life cycle of P1 while Flp recombinase was originally derived from the 2 μ circle of Saccharomyces cerevisiae and catalyzes recombination between inverted repeats within the 2 μ plasmid. This chapter shall provide a brief historical perspective on the discovery and early development of the Cre/loxP and FRT/FLP systems citing key studies that paved the way for the application of these site-specific recombination technologies to the engineering of mammalian genomes. Also included are discussions on the mechanisms of Cre/loxP and FRT/FLP systems application of these site-specific recombinase technologies to the introduction of transgenes in human pluripotent stem cells. Certain studies using mouse pluripotent stem cells will also be discussed in order to highlight the possibility of adopting the same strategy in their human counterparts. Lastly, future prospects for these two site-specific recombinases will be presented.
Rights: The final publication is available at www.springerlink.com
This is not the published version. Please cite only the published version. この論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。
URI: http://hdl.handle.net/2433/160128
DOI(Published Version): 10.1007/978-94-007-4531-5_7
Appears in Collections:Journal Articles

Export to RefWorks

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


Powered by DSpace 3.2.0 and JAIRO Crawler-List version 1.1
All items in KURENAI are protected by original copyright, with all rights reserved, unless otherwise indicated.